Remission of severe myasthenia gravis after autologous stem cell transplantation

OBJECTIVE: Myasthenia gravis (MG) is an autoantibody‐mediated neuromuscular junction disorder involving the acetylcholine receptors on the motor endplate. The safety and response to high‐dose chemotherapy (HDIT) and autologous hematopoietic cell transplantation (HCT) were assessed in a patient with...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlatter, Monica I., Yandamuri, Soumya S., O'Connor, Kevin C., Nowak, Richard J., Pham, Minh C., Obaid, Abeer H., Redman, Callee, Provost, Marie, McSweeney, Peter A., Pearlman, Michael L., Tees, Michael T., Bowen, James D., Nash, Richard A., Georges, George E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646993/
https://www.ncbi.nlm.nih.gov/pubmed/37726935
http://dx.doi.org/10.1002/acn3.51898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646993/
https://www.ncbi.nlm.nih.gov/pubmed/37726935
http://dx.doi.org/10.1002/acn3.51898

Ejemplares similares